Peter Wicki

744 total citations
13 papers, 634 citations indexed

About

Peter Wicki is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Peter Wicki has authored 13 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in Peter Wicki's work include Neuroscience and Neuropharmacology Research (11 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neural Engineering (3 papers). Peter Wicki is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neural Engineering (3 papers). Peter Wicki collaborates with scholars based in Switzerland. Peter Wicki's co-authors include J.-J. Feldtrauer, P. C. Waldmeier, Pascal Frey, Claire Goldsbury, Ueli Aebi, P. A. Baumann, Peter Baumann, Markus Schmutz, H. Bittiger and Stuart J. Mickel and has published in prestigious journals such as Neurology, British Journal of Pharmacology and Journal of Structural Biology.

In The Last Decade

Peter Wicki

12 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Wicki Switzerland 9 388 330 242 80 74 13 634
K. Scheuer Germany 9 206 0.5× 157 0.5× 226 0.9× 29 0.4× 28 0.4× 9 482
Donna L. Maier United States 13 276 0.7× 295 0.9× 257 1.1× 98 1.2× 11 0.1× 21 725
Michael L. Cornfeldt United States 15 400 1.0× 474 1.4× 58 0.2× 60 0.8× 18 0.2× 25 932
Wia Timmerman Netherlands 14 328 0.8× 548 1.7× 144 0.6× 89 1.1× 5 0.1× 26 931
Viktor Szegedi Hungary 19 294 0.8× 318 1.0× 332 1.4× 23 0.3× 25 0.3× 34 758
Jürg Messer Switzerland 10 385 1.0× 448 1.4× 342 1.4× 41 0.5× 14 0.2× 12 787
Marcelo Ganzella Germany 19 439 1.1× 317 1.0× 115 0.5× 59 0.7× 5 0.1× 35 904
Paula Huntington United States 11 271 0.7× 216 0.7× 236 1.0× 16 0.2× 8 0.1× 12 774
Charles Vargas-Lopes Brazil 10 299 0.8× 277 0.8× 186 0.8× 49 0.6× 6 0.1× 10 750
Athanasios Metaxas Denmark 17 314 0.8× 263 0.8× 257 1.1× 44 0.6× 5 0.1× 40 723

Countries citing papers authored by Peter Wicki

Since Specialization
Citations

This map shows the geographic impact of Peter Wicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wicki more than expected).

Fields of papers citing papers by Peter Wicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wicki. The network helps show where Peter Wicki may publish in the future.

Co-authorship network of co-authors of Peter Wicki

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wicki. A scholar is included among the top collaborators of Peter Wicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wicki. Peter Wicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & Peter Baumann. (2004). Ca2+-dependent release of endogenous GABA from rat cortical slices from different pools by different stimulation conditions. Naunyn-Schmiedeberg s Archives of Pharmacology. 339-339(1-2). 200–207.
2.
Goldsbury, Claire, et al.. (2000). Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors. Journal of Structural Biology. 130(2-3). 217–231. 237 indexed citations
3.
Wicki, Peter, et al.. (1995). Effects of the putative P-type calcium channel blocker, R,R-(?)-daurisoline on neurotransmitter release. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(6). 670–8. 8 indexed citations
4.
Waldmeier, P. C., et al.. (1995). Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 45(10). 1907–1913. 109 indexed citations
5.
Waldmeier, P. C. & Peter Wicki. (1994). GABA release in rat cortical slices is unable to cope with demand if the autoreceptor is blocked. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(6). 583–587. 2 indexed citations
6.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, et al.. (1994). GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. British Journal of Pharmacology. 113(4). 1515–1521. 82 indexed citations
7.
Wicki, Peter, et al.. (1993). Effects of CGP 28014 on the in vivo release and metabolism of dopamine in the rat striatum assessed by brain microdialysis. Neurochemical Research. 18(11). 1131–1136. 6 indexed citations
8.
Wicki, Peter, et al.. (1993). Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(5). 478–85. 26 indexed citations
9.
Waldmeier, P. C., et al.. (1993). Autoreceptor-mediated regulation of GABA release: role of uptake inhibition and effects of novel GABAB antagonists. Naunyn-Schmiedeberg s Archives of Pharmacology. 347(5). 514–520. 16 indexed citations
10.
Baumann, P. A., et al.. (1990). Investigations on GABAB receptor-mediated autoinhibition of GABA release. Naunyn-Schmiedeberg s Archives of Pharmacology. 341-341(1-2). 88–93. 36 indexed citations
11.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & Peter Baumann. (1989). Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(4). 372–378. 14 indexed citations
12.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & P. A. Baumann. (1988). The measurement of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 284–8. 21 indexed citations
13.
Wicki, Peter, et al.. (1988). Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 289–95. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026